APA (7th ed.) Citation

J, B., S, L. G., MC, F., BP, R., & JM, B. (2003). Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: A c-Fos study in the rat spinal cord. European journal of pain (London, England), 7(3), 241. https://doi.org/10.1016/S1090-3801(02)00122-2

Chicago Style (17th ed.) Citation

J, Buritova, Le Guen S, Fournié-Zaluski MC, Roques BP, and Besson JM. "Antinociceptive Effects of RB101(S), a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by (+)-HA966, a Functional NMDA Receptor Antagonist: A C-Fos Study in the Rat Spinal Cord." European Journal of Pain (London, England) 7, no. 3 (2003): 241. https://doi.org/10.1016/S1090-3801(02)00122-2.

MLA (9th ed.) Citation

J, Buritova, et al. "Antinociceptive Effects of RB101(S), a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by (+)-HA966, a Functional NMDA Receptor Antagonist: A C-Fos Study in the Rat Spinal Cord." European Journal of Pain (London, England), vol. 7, no. 3, 2003, p. 241, https://doi.org/10.1016/S1090-3801(02)00122-2.